Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CARBIDOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CARBIDOPA: Safety Overview

Metric CAPMATINIB CARBIDOPA
Total FAERS Reports 2,301 302
Deaths Reported 583 41
Death Rate 25.3% 13.6%
Hospitalizations 388 122
Average Patient Age 71.9 yrs 71.3 yrs
% Female Patients 53.9% 44.3%
FDA Approval Date May 6, 2020 Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation Dr. Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Prescription